Biological activity of the main metabolites of ubenimex in humans.
- 1 January 1988
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 41 (12) , 1862-1867
- https://doi.org/10.7164/antibiotics.41.1862
Abstract
The biological activity of the two main metabolites of ubenimex in humans, (-)-N- [(2S,3R)-3-amino-2-hydroxy-4-(4''-hydroxy)phenylbutyryl]-L-leucine (OH-ubenimex) and (2S,3R)-3-amino-2-hydroxy-4-phenylbutyric acid (2S,3R)-AHPA) was examined, OH-Ubenimex was almost identical in inhibitory activity against mouse peritoneal resident macrophage aminopeptidases (APases) and the growth of IMC carcinoma in mice to ubenimex. In contrast, the inhibition of; mouse spleen cell APase activities in vitro, blastogenases of mouse T and B cells in vitro, delayed cutaneous hypersensitivity in mice, and the growth of C1498 leukemia and HeLa S3 cells in vitro was weaker than ubenimex. Macrophage APase activity was only slightly inhibited by (2S,3R)-AHPA which also had practically no activity in the other biological assays.This publication has 3 references indexed in Scilit:
- The effect of ubenimex on N-methyl-N'-nitro-N-nitrosoguanidine-induced stomach tumor in rats.The Journal of Antibiotics, 1986
- RESTORATION OF IMPAIRED IMMUNE FUNCTIONS OF AGED ANIMALS BY CHRONIC BESTATIN TREATMENT1979
- Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase.The Journal of Antibiotics, 1976